Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positiveOramed strategic transaction ...

Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new oral ...

Analysts have cut Globant’s fair value estimate from $84.64 to $73.36, a reduction of about 13% in the updated price target. This reset sits alongside a split narrative on the Street, with some ...

The spatio-temporal evolution of wall-bounded turbulence is characterized by high nonlinearity, multi-scale dynamics, and chaotic nature, making its accurate prediction a significant challenge for ...

Cibus (NASDAQ:CBUS) used its fourth quarter 2025 results call to highlight a year the company described as a commercial and ...